These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30517737)

  • 1. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
    Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
    J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome.
    Lebensohn A; Ghafoor A; Bloomquist L; Royer MC; Castelo-Soccio L; Karacki K; Hathaway O; Maglo T; Wagner C; Agra MG; Blakely AM; Schrump DS; Hassan R; Cowen EW
    JAMA Dermatol; 2024 Aug; 160(8):838-845. PubMed ID: 38759225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
    Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
    Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
    Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
    Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
    BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional assay for assessment of pathogenicity of BAP1 variants.
    Repo PE; Backlund MP; Kivelä TT; Turunen JA
    Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
    Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
    Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
    JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
    Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1-associated protein 1: Tumor predisposition syndrome and Kury-Isidor syndrome, from genotype-phenotype correlation to clinical management.
    West EC; Chiappetta M; Mattingly AA; Congedo MT; Evangelista J; Campanella A; Sassorossi C; Flamini S; Rossi T; Pistoni M; Abenavoli L; Margaritora S; Lococo F; Boccuto L
    Clin Genet; 2024 Jun; 105(6):589-595. PubMed ID: 38506155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAPoma presenting as an incidental scalp papule: case report, literature review, and screening recommendations for BAP1 tumor predisposition syndrome.
    Zaayman M; Nguyen P; Silfvast-Kaiser A; Frieder J; West C; Tumminello K; Paek SY
    J Dermatolog Treat; 2022 Jun; 33(4):1855-1860. PubMed ID: 34106034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based analysis of germline BAP1 mutations in melanoma.
    O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
    Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
    Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
    Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
    Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
    BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant.
    Goldberg Y; Laitman Y; Ben David M; Bazak L; Lidzbarsky G; Salmon LB; Shkedi-Rafid S; Barshack I; Avivi C; Darawshe M; Shomron N; Bruchim R; Vinkler C; Yannoukakos D; Fostira F; Bernstein-Molho R; Friedman E
    Hum Mutat; 2021 May; 42(5):592-599. PubMed ID: 33600035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
    Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P
    JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome.
    Lalloo F; Kulkarni A; Chau C; Nielsen M; Sheaff M; Steele J; van Doorn R; Wadt K; Hamill M; Torr B; Tischkowitz M; ; Hanson H
    Eur J Hum Genet; 2023 Nov; 31(11):1261-1269. PubMed ID: 37607989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
    Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
    PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.